UK Gets First Publicly Available Dedicated Cannabis Research Facility

adminNews0 Comments

<![CDATA[

Cannabinoid biotechnology company MediPen is launching its own dedicated 1,800-square-foot marijuana research facility this summer, which will also provide a platform for anyone looking to utilize its facilities for the purposes of driving innovation around the use of medicinal cannabis.

The company, which has had big success selling non-psychoactive CBD vaporizers that users claim to have a long list of medicinal benefits, is currently in the process of securing a license from the Home Office to import and work with controlled compounds found in cannabis so it can study the plant in greater detail.

RELATED: International Cannabis News

These include ?9-Tetrahydrocannabinol (THC), which will be studied in the laboratory with regard to cancer patients and with the aim of minimizing the negative impact of existing chemotherapy-based treatments such as nausea and vomiting through its antiemetic properties, along with attempting to suppress metastasis through inhibiting the proliferation of cancer cells.

Read more.

]]>
Source: Cannabis Business Times

Leave a Reply

Your email address will not be published. Required fields are marked *